Faeth Therapeutics, Inc. (FTH)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch FTH
Latest sale
$501k
Jun 1 · No plan
Form 4 sales
12
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Dec 5 2025

    Sold 21,295 shares at $10.93 ($233k)

    Cambrian BioPharma Inc, 10% owner

    No 10b5-1 planSold 11.7% of holdings ($2M position)161,359 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleNo plan
    Dec 9 +4 days

    Sold 6,612 shares at $8.25 ($55k)

    Peyer James, 10% owner

    No 10b5-1 planSold 4.1% of holdings ($1.3M position)155,142 shares leftFiling

  3. 3 Form 4 saleNo plan
    Dec 9 same day

    Sold 6,612 shares at $8.25 ($55k)

    Cambrian BioPharma Inc, 10% owner

    No 10b5-1 planSold 4.1% of holdings ($1.3M position)155,142 shares leftFiling

  4. 4 Form 4 saleNo plan
    Mar 30 +111 days

    Sold 3,250 shares at $27.51 ($89k)

    Ics Opportunities II LLC, 10% owner

    No 10b5-1 planSold 2.2% of holdings ($4.1M position)145,678 shares leftFirst sale on recordFiling

  5. 5 Form 4 saleNo plan
    Apr 1 +2 days

    Sold 2,741 shares at $28.07 ($77k)

    Millennium Management LLC, 10% owner

    No 10b5-1 planSold 1.8% of holdings ($4.2M position)147,731 shares leftFirst sale on recordFiling

  6. 6 Form 4 saleNo plan
    Apr 7 +6 days

    Sold 17,076 shares at $31.51 ($538k)

    Ics Opportunities II LLC, 10% owner

    No 10b5-1 planSold 11.3% of holdings ($4.8M position)133,986 shares leftFiling

  7. 7 Form 4 saleNo plan
    Jun 1 +55 days

    Sold 25,000 shares at $20.02 ($501k)

    Peyer James, 10% owner

    No 10b5-1 planSold 16.1% of holdings ($3.1M position)130,142 shares leftFiling

  8. 8 Form 4 saleNo plan
    Jun 1 same day

    Sold 25,000 shares at $20.02 ($501k)

    Cambrian BioPharma Inc, 10% owner

    No 10b5-1 planSold 16.1% of holdings ($3.1M position)130,142 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (12)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for FTH
Source
Jun 1, 2026Cambrian BioPharma Inc10% ownerForm 4 sale25,000$501k16.1%No planSEC
Jun 1, 2026Peyer James10% ownerForm 4 sale25,000$501k16.1%No planSEC
Apr 7, 2026Ics Opportunities II LLC10% ownerForm 4 sale17,076$538k11.3%No planSEC
Apr 1, 2026Millennium Management LLC10% ownerForm 4 sale2,741$77k1.8%No planSEC
Mar 30, 2026Ics Opportunities II LLC10% ownerForm 4 sale3,250$89k2.2%No planSEC
Dec 9, 2025Cambrian BioPharma Inc10% ownerForm 4 sale6,612$55k4.1%No planSEC
Dec 9, 2025Peyer James10% ownerForm 4 sale6,612$55k4.1%No planSEC
Dec 5, 2025Cambrian BioPharma Inc10% ownerForm 4 sale21,295$233k11.7%No planSEC
Dec 5, 2025Peyer James10% ownerForm 4 sale21,295$233k11.7%No planSEC
Jun 1, 2023Angermayer Christian10% ownerForm 4 sale3.4M$5.4M100.0%UnusualSEC
Aug 11, 2021Pierce Robert HamiltonChief Scientific OfficerForm 4 sale16,030$118k100.0%UnusualSEC
Aug 10, 2021Pierce Robert HamiltonChief Scientific OfficerForm 4 sale79,792$568k83.3%UnusualSEC